IRIS - Res&Arch Institutional Research Information System - Research & Archive

MARTELLI, Massimo Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.793
EU - Europa 6.478
AS - Asia 5.706
SA - Sud America 915
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 22.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.609
SG - Singapore 2.624
UA - Ucraina 1.144
IE - Irlanda 1.061
SE - Svezia 862
CN - Cina 793
RU - Federazione Russa 781
HK - Hong Kong 709
BR - Brasile 690
IT - Italia 688
VN - Vietnam 561
DE - Germania 525
FI - Finlandia 419
FR - Francia 331
KR - Corea 294
GB - Regno Unito 270
IN - India 135
BD - Bangladesh 97
TR - Turchia 91
CA - Canada 89
AR - Argentina 84
IQ - Iraq 66
BE - Belgio 60
PL - Polonia 54
MX - Messico 53
NL - Olanda 51
ZA - Sudafrica 49
UZ - Uzbekistan 46
JP - Giappone 44
AT - Austria 42
CZ - Repubblica Ceca 41
PK - Pakistan 38
CO - Colombia 35
EC - Ecuador 31
CH - Svizzera 28
SA - Arabia Saudita 27
ID - Indonesia 26
VE - Venezuela 23
ES - Italia 21
JO - Giordania 21
MA - Marocco 18
RO - Romania 18
LT - Lituania 17
PH - Filippine 17
GR - Grecia 16
BO - Bolivia 14
CL - Cile 14
KE - Kenya 13
LB - Libano 13
PY - Paraguay 13
DZ - Algeria 12
EG - Egitto 12
TN - Tunisia 12
MY - Malesia 11
IL - Israele 10
AE - Emirati Arabi Uniti 9
ET - Etiopia 9
JM - Giamaica 9
OM - Oman 9
AL - Albania 8
AZ - Azerbaigian 8
CR - Costa Rica 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
EU - Europa 7
KZ - Kazakistan 7
BG - Bulgaria 6
NP - Nepal 6
KG - Kirghizistan 5
PE - Perù 5
PT - Portogallo 5
AU - Australia 4
DK - Danimarca 4
GE - Georgia 4
RS - Serbia 4
SI - Slovenia 4
AM - Armenia 3
EE - Estonia 3
HR - Croazia 3
KW - Kuwait 3
MM - Myanmar 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
TW - Taiwan 2
Totale 22.016
Salva come PNG Salva come JPEG
Città #
Singapore 1.861
Chandler 1.232
Dublin 1.061
San Jose 768
Hong Kong 706
San Mateo 670
Jacksonville 636
Ashburn 542
Boardman 396
Ann Arbor 304
Santa Clara 294
Seoul 288
Moscow 248
Medford 226
Princeton 224
Dong Ket 215
Beijing 213
Lauterbourg 199
Altamura 191
Perugia 175
Wilmington 164
Andover 161
Munich 152
Lawrence 140
Los Angeles 133
New York 132
Piscataway 118
Helsinki 115
Ho Chi Minh City 104
The Dalles 80
Turku 80
Hanoi 64
Woodbridge 63
Saint Petersburg 62
Brussels 57
São Paulo 55
Norwalk 54
Orem 51
Frankfurt am Main 47
Shanghai 47
Houston 46
Des Moines 42
London 42
Tokyo 42
Brooklyn 34
Dallas 34
Dearborn 34
Izmir 33
Council Bluffs 32
San Paolo di Civitate 32
Montreal 31
Stockholm 31
Warsaw 31
Johannesburg 30
Atlanta 29
Baghdad 27
Amsterdam 26
Auburn Hills 26
Phoenix 26
Falkenstein 25
Milan 25
Chennai 24
Denver 24
Brno 23
Rio de Janeiro 23
Chicago 21
San Francisco 21
Redwood City 20
Rome 20
Tashkent 20
Boston 19
Nuremberg 19
San Diego 19
Mexico City 18
Bologna 17
Da Nang 17
Foligno 17
Quito 17
Amman 16
Ankara 15
Belo Horizonte 15
Charlotte 15
Manchester 15
Brasília 14
Hefei 14
Lahore 14
Toronto 14
Guangzhou 13
New Delhi 13
Poplar 13
Buenos Aires 12
Espoo 12
Falls Church 12
Haiphong 12
Redmond 12
Campinas 11
Dhaka 11
Istanbul 11
Mumbai 11
Nairobi 11
Totale 13.631
Salva come PNG Salva come JPEG
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 187
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 173
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 172
Innate immunity against hematological malignancies 163
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 156
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 156
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 155
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 147
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 146
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults 145
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 144
A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma 144
14q+ chromosome marker in a T-cell-rich B-cell lymphoma. 143
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 143
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 140
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 140
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 139
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 137
Graft engineering for allogeneic haploidentical stem cell transplantation 135
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 130
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 129
Acute lymphoblastic leukaemia in Noonan syndrome 129
Fourth international workshop on haploidentical transplants, Naples, Italy 126
Mesenchymal cells: a vehicle for gene therapy 125
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 125
3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. 124
A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement 124
"Designed" grafts for HLA-haploidentical stem cell transplantation. 124
5q- syndrome termi¬nating in acute myeloid leukemia: karyotype evolution and immunological characterization of blast cells. 123
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 123
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 123
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 122
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 122
5q- syndrome in a patient with chronic exposure to ionizing radiation. 121
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 121
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 121
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 121
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 120
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 118
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 118
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 118
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 117
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 117
t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia 117
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 117
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 117
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 117
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 116
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 115
Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies 115
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 114
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 114
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases 114
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 113
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 112
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 111
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 111
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 110
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 110
T regulatory cell separation for clinical application. 110
Decreased bone mineral density after autologous stem cell transplantation. 109
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene 109
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 108
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 107
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 107
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 106
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 106
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 106
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 106
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 105
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 105
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 105
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 105
Allogeneic transplantation across the HLA barriers. 105
AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer 105
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 105
Transplants across human leukocyte antigen barriers 104
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 104
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 104
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 103
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells 103
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 103
. Mismatched hematopoietic stem cell transplants in elderly patients. 103
The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects 102
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 101
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 101
Natural killer cell alloreactivity for leukemia therapy. 101
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia 100
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 100
Submicroscopic deletions in 5q- associated malignancies 100
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 100
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 99
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 99
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 98
Quantitative detection of NPM1 mutations as marker of minimal residual disease (MRD) in the large majority of AML with normal karyotype 98
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 98
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 98
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 98
Different genomic imbalances in low- and high-grade HCV-related lymphomas 97
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 97
Totale 11.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 0 0 0 0 0 0 254
2021/20222.169 55 525 71 175 94 11 30 620 18 39 266 265
2022/20233.658 253 631 26 336 276 384 4 200 1.391 12 113 32
2023/20241.503 85 156 64 31 10 20 320 43 197 40 251 286
2024/20253.323 93 347 136 156 446 144 91 251 619 185 565 290
2025/20267.330 535 476 336 974 1.056 728 1.181 371 823 648 159 43
Totale 22.526